NCT06539026 Inferior Vena Cava Collapsibility Index Guide for Preoperative Fluid Therapy in Preeclampsia
| NCT ID | NCT06539026 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Pre-Eclampsia |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-08-15 |
| Primary Completion | 2024-11-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-08-15 with a primary completion date of 2024-11-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The routine assessment of fluid status depends on clinical evaluation and invasive monitoring. The clinical assessment lacks objectivity and the invasive monitoring carries risks. Point of care ultrasound (POCUS) parameters can be useful as early markers of fluid status and were used in safe fluid assessment in term pregnancy and preeclampsia.
Eligibility Criteria
Inclusion Criteria: * Critically ill pre-eclamptic patients for cesarean section Exclusion Criteria: * Patient refusal * severe cardiovascular disease ( ejection fraction \< 40 mmHg ), tricuspid regurge. * contraindication for spinal anesthesia. * failure to perform spinal anesthesia. * severe hepatic. * renal dysfunction
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06539026 clinical trial?
This trial is open to female participants only, studying Pre-Eclampsia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06539026 currently recruiting?
Yes, NCT06539026 is actively recruiting participants. Contact the research team at w.z.selima@med.asu.edu.eg for enrollment information.
Where is the NCT06539026 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06539026 clinical trial?
NCT06539026 is sponsored by Ain Shams University. The trial plans to enroll 90 participants.